Kaumaya PT - Search Results

1

Conformational HER-2/neu B-cell epitope peptide vaccine designed to incorporate two native disulfide bonds enhances tumor cell binding and antitumor activities.

Dakappagari NK, Lute KD, Rawale S, Steele JT, Allen SD, Phillips G, Reilly RT, Kaumaya PT. Dakappagari NK, et al. Among authors: kaumaya pt. J Biol Chem. 2005 Jan 7;280(1):54-63. doi: 10.1074/jbc.M411020200. Epub 2004 Oct 26. J Biol Chem. 2005. PMID: 15507452 Free article.

2

Design and immunological properties of topographic immunogenic determinants of a protein antigen (LDH-C4) as vaccines.

Kaumaya PT, VanBuskirk AM, Goldberg E, Pierce SK. Kaumaya PT, et al. J Biol Chem. 1992 Mar 25;267(9):6338-46. J Biol Chem. 1992. PMID: 1372905 Free article.

3

Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.

Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V. Kaumaya PT, et al. J Mol Recognit. 1993 Jun;6(2):81-94. doi: 10.1002/jmr.300060206. J Mol Recognit. 1993. PMID: 7508238

4

Engineered topographic determinants with alpha beta, beta alpha beta, and beta alpha beta alpha topologies show high affinity binding to native protein antigen (lactate dehydrogenase-C4).

Kobs-Conrad S, Lee H, DiGeorge AM, Kaumaya PT. Kobs-Conrad S, et al. Among authors: kaumaya pt. J Biol Chem. 1993 Dec 5;268(34):25285-95. J Biol Chem. 1993. PMID: 8244959 Free article.

5

Subunit peptide cancer vaccines targeting activating mutations of the p21 ras proto-oncogene.

Triozzi PL, Stoner GD, Kaumaya PT. Triozzi PL, et al. Among authors: kaumaya pt. Biomed Pept Proteins Nucleic Acids. 1995;1(3):185-92. Biomed Pept Proteins Nucleic Acids. 1995. PMID: 9346851

6

Immunogenicity and conformational properties of an N-linked glycosylated peptide epitope of human T-lymphotropic virus type 1 (HTLV-I).

Conrad SF, Byeon IJ, DiGeorge AM, Lairmore MD, Tsai MD, Kaumaya PT. Conrad SF, et al. Among authors: kaumaya pt. Biomed Pept Proteins Nucleic Acids. 1995;1(2):83-92. Biomed Pept Proteins Nucleic Acids. 1995. PMID: 9346859

7

Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.

Dakappagari NK, Douglas DB, Triozzi PL, Stevens VC, Kaumaya PT. Dakappagari NK, et al. Among authors: kaumaya pt. Cancer Res. 2000 Jul 15;60(14):3782-9. Cancer Res. 2000. PMID: 10919651

8

Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide.

Frangione-Beebe M, Albrecht B, Dakappagari N, Rose RT, Brooks CL, Schwendeman SP, Lairmore MD, Kaumaya PT. Frangione-Beebe M, et al. Among authors: kaumaya pt. Vaccine. 2000 Dec 8;19(9-10):1068-81. doi: 10.1016/s0264-410x(00)00340-6. Vaccine. 2000. PMID: 11137241

9

Synthetic peptides as cancer vaccines.

Sundaram R, Dakappagari NK, Kaumaya PT. Sundaram R, et al. Among authors: kaumaya pt. Biopolymers. 2002;66(3):200-16. doi: 10.1002/bip.10258. Biopolymers. 2002. PMID: 12385038 Review.

10

A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses.

Dakappagari NK, Pyles J, Parihar R, Carson WE, Young DC, Kaumaya PT. Dakappagari NK, et al. Among authors: kaumaya pt. J Immunol. 2003 Apr 15;170(8):4242-53. doi: 10.4049/jimmunol.170.8.4242. J Immunol. 2003. PMID: 12682258

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters